Sign in

NCT07066137Recruiting

Motor Learning in Health and Movement Disorders: Role of Physical Activity and Advanced Devices

Motor Planning, Execution, and Modulation in Healthy Individuals and Patients With Movement Disorders or Neuromuscular Diseases Using Traditional Physical Activity or Advanced Devices to Enhance Motor Learning and Sensorimotor Processing

Source: ClinicalTrials.gov · Last updated 3 Nov 2026

Brief summary (registry, in English)

The goal of this clinical trial is to investigate motor responses in healthy subjects and patients with movement disorders, brain and spinal cord injury, neuromuscular diseases, or cardiovascular diseases. This study aims to evaluate the effectiveness of traditional physical activities combined with innovative interventions such as cryotherapy, ultrasound therapy, laser therapy, transcranial magnetic stimulation (TMS), and transcranial direct current stimulation (tDCS). It will also assess the impact of proprioceptive stimuli provided by either the immersive virtual reality (CAREN), or visuo-cognitive-motor enhancement (S.V.T.A.), and music therapy. The main questions it aims to answer are: How do these interventions affect motor activities and their functional recovery? What are the temporal and spatial changes in activation sequences related to motor learning and maintenance? When there is a comparison group: Researchers will compare outcomes between different intervention arms (e.g., physical activity with advanced devices vs. traditional methods) to find out if the advanced interventions result in better motor control and functional recovery. Participants will: * Undergo various rehabilitation protocols including physical activity and advanced interventions. * Be assessed using different tool, such as fMRI, dtMRI, and NIRS to study in vivo neuroimaging and assess changes in brain function and connectivity.

Status (registry)
Recruiting
Study type
Interventional
Enrollment
150 (estimated)
First submitted
9 Oct 2024
Start date
5 May 2024
Primary completion date
6 Dec 2028
Lead sponsor
IRCCS Centro Neurolesi Bonino Pulejo
NCT number
NCT07066137

What you commit to

  • Study type: Interventional
  • Planned participants: 150
  • From 5 May 2024 to the primary completion date, 6 Dec 2028
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Severe medical and psychiatric disorders potentially affecting the training

Who the study is looking for

  • Montreal Cognitive Assessment (MoCA) score (adjusted for age and education) equal to or greater than 20.

Age in the registry: 18 years to 70 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS Centro Neurolesi Bonino Pulejo
Coordinator of this site? Confirm its status
MessinaItalyRecruiting

Related publications

This page is information, not medical advice. Discuss any trial with your doctor.